首页> 美国卫生研究院文献>Case Reports in Oncology >Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report
【2h】

Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report

机译:Redaporfin光动力疗法治疗头颈癌的临床病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Advanced head and neck squamous cell carcinoma, after locoregional treatment and multiple lines of systemic therapies, represents a great challenge to overcome acquired resistance. The present clinical case illustrates a successful treatment option and is the first to describe the use of photodynamic therapy (PDT) with Redaporfin, followed by immune checkpoint inhibition with an anti-PD1 antibody. This patient presented an extensive tumor in the mouth pavement progressing after surgery, radiotherapy, and multiple lines of systemic treatment. PDT with Redaporfin achieved the destruction of all visible tumor, and the sequential use of an immune checkpoint inhibitor allowed a sustained complete response. This case is an example of the effect of this therapeutic combination and may provide the basis for a new treatment modality.
机译:局部区域治疗和多种系统疗法后,晚期头颈部鳞状细胞癌代表了克服获得性耐药的巨大挑战。本临床病例说明了成功的治疗选择,并且是第一个描述使用Redaporfin进行光动力疗法(PDT),然后使用抗PD1抗体抑制免疫检查点的方法。该患者在手术,放疗和多线全身治疗后,口腔中出现了广泛的肿瘤。带有Redaporfin的PDT实现了所有可见肿瘤的破坏,并且连续使用免疫检查点抑制剂可实现持续的完全应答。这种情况是这种治疗组合的效果的一个例子,并且可以为新的治疗方式提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号